Cargando…

TM4SF1 Promotes Gemcitabine Resistance of Pancreatic Cancer In Vitro and In Vivo

BACKGROUND: TM4SF1 is overexpressed in pancreatic ductal adenocarcinoma (PDAC) and affects the development of this cancer. Also, multidrug resistance (MDR) is generally associated with tumor chemoresistance in pancreatic cancer. However, the correlation between TM4SF1 and MDR remains unknown. This r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Jia, Yang, Jiachun, Ramachandran, Vijaya, Arumugam, Thiruvengadam, Deng, Defeng, Li, Zhaoshen, Xu, Leiming, Logsdon, Craig D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4692438/ https://www.ncbi.nlm.nih.gov/pubmed/26709920 http://dx.doi.org/10.1371/journal.pone.0144969

Ejemplares similares

Targeting Pancreatic Ductal Adenocarcinoma Acidic Microenvironment
por: Cruz-Monserrate, Zobeida, et al.
Publicado: (2014)

The ADMR Receptor Mediates the Effects of Adrenomedullin on Pancreatic Cancer Cells and on Cells of the Tumor Microenvironment
por: Ramachandran, Vijaya, et al.
Publicado: (2009)

Targeting TM4SF5 with anti-TM4SF5 monoclonal antibody suppresses the growth and motility of human pancreatic cancer cells
por: Park, Sangkyu, et al.
Publicado: (2020)

TM4SF1 Promotes Metastasis of Pancreatic Cancer via Regulating the Expression of DDR1
por: Yang, Jia-chun, et al.
Publicado: (2017)

Three Members of Transmembrane-4-Superfamily, TM4SF1, TM4SF4, and TM4SF5, as Emerging Anticancer Molecular Targets against Cancer Phenotypes and Chemoresistance
por: Rahim, Nur Syafiqah, et al.
Publicado: (2023)

TM4SF18 is aberrantly expressed in pancreatic cancer and regulates cell growth
por: Singhal, Megha, et al.
Publicado: (2019)

Down-regulation of TM4SF is associated with the metastatic potential of gastric carcinoma TM4SF members in gastric carcinoma
por: Chen, Zhouxun, et al.
Publicado: (2011)

Inhibitory effect of metformin combined with gemcitabine on pancreatic cancer cells in vitro and in vivo
por: Shi, Yuqi, et al.
Publicado: (2016)

Mechanism and therapeutic strategy of hepatic TM6SF2-deficient non-alcoholic fatty liver diseases via in vivo and in vitro experiments
por: Li, Zu-Yin, et al.
Publicado: (2022)

Huaier increases the antitumor effect of gemcitabine on pancreatic cancer in vitro and in vivo
por: Chen, Tao, et al.
Publicado: (2021)

LINC01232 exerts oncogenic activities in pancreatic adenocarcinoma via regulation of TM9SF2
por: Li, Qian, et al.
Publicado: (2019)

Myeloid TM6SF2 Deficiency Inhibits Atherosclerosis
por: Zhu, Wenzhen, et al.
Publicado: (2022)

Anti-cancer Activity of Novel TM4SF5-Targeting Antibodies through TM4SF5 Neutralization and Immune Cell-Mediated Cytotoxicity
por: Ahn, Hye-Mi, et al.
Publicado: (2017)

Pomalidomide enhanced gemcitabine and nab-paclitaxel on pancreatic cancer both in vitro and in vivo
por: Saito, Nobuhiro, et al.
Publicado: (2018)

Piperlongumine potentiates the effects of gemcitabine in in vitro and in vivo human pancreatic cancer models
por: Mohammad, Jiyan, et al.
Publicado: (2017)

TM4SF5-Mediated Roles in the Development of Fibrotic Phenotypes
por: Ryu, Jihye, et al.
Publicado: (2017)

Overexpressed Galectin-3 in Pancreatic Cancer Induces Cell Proliferation and Invasion by Binding Ras and Activating Ras Signaling
por: Song, Shumei, et al.
Publicado: (2012)

Fasting cycles potentiate the efficacy of gemcitabine treatment in in vitro and in vivo pancreatic cancer models
por: D'Aronzo, Martina, et al.
Publicado: (2015)

Clinical significance of TM4SF1 as a tumor suppressor gene in gastric cancer
por: Peng, Xing‐Chun, et al.
Publicado: (2018)

Met Receptor Tyrosine Kinase Signaling Induces Secretion of the Angiogenic Chemokine Interleukin-8/CXCL8 in Pancreatic Cancer
por: Hill, Kristen S., et al.
Publicado: (2012)

TM4SF5-mediated protein-protein networks and tumorigenic roles
por: Lee, Jung Weon
Publicado: (2014)

The loss of Tm7sf gene accelerates skin papilloma formation in mice
por: Bellezza, I., et al.
Publicado: (2015)

Amino acid transporters as tetraspanin TM4SF5 binding partners
por: Jung, Jae Woo, et al.
Publicado: (2020)

Predictive Modeling of In Vivo Response to Gemcitabine in Pancreatic Cancer
por: Lee, James J., et al.
Publicado: (2013)

An in vitro and in vivo study of gemcitabine-loaded albumin nanoparticles in a pancreatic cancer cell line
por: Yu, Xinzhe, et al.
Publicado: (2015)

The Antitumor Activity of Sodium Selenite Alone and in Combination with Gemcitabine in Pancreatic Cancer: An In Vitro and In Vivo Study
por: Doello, Kevin, et al.
Publicado: (2021)

N-terminus-independent activation of c-Src via binding to a tetraspan(in) TM4SF5 in hepatocellular carcinoma is abolished by the TM4SF5 C-terminal peptide application
por: Song, Haeng Eun, et al.
Publicado: (2021)

Plectin-1 Targeted AAV Vector for the Molecular Imaging of Pancreatic Cancer
por: Konkalmatt, Prasad R., et al.
Publicado: (2013)

TM6SF2 and MBOAT7 Gene Variants in Liver Fibrosis and Cirrhosis
por: Basyte-Bacevice, Viktorija, et al.
Publicado: (2019)

Deferasirox, an oral iron chelator, with gemcitabine synergistically inhibits pancreatic cancer cell growth in vitro and in vivo
por: Shinoda, Shuhei, et al.
Publicado: (2018)

In vitro and in vivo characterization of four fibroblast tropomyosins produced in bacteria: TM-2, TM-3, TM-5a, and TM-5b are co-localized in interphase fibroblasts
Publicado: (1992)

TM4SF1 promotes esophageal squamous cell carcinoma metastasis by interacting with integrin α6
por: Hou, Sicong, et al.
Publicado: (2022)

Synergistic activity of troxacitabine (Troxatyl™) and gemcitabine in pancreatic cancer
por: Damaraju, Vijaya L, et al.
Publicado: (2007)

A Novel Role for Tm7sf2 Gene in Regulating TNFα Expression
por: Bellezza, Ilaria, et al.
Publicado: (2013)

TM4SF1 is a potential target for anti-invasion and metastasis in ovarian cancer
por: Gao, Caiyun, et al.
Publicado: (2019)

TM4SF1 Promotes Proliferation, Invasion, and Metastasis in Human Liver Cancer Cells
por: Huang, Yu-Kun, et al.
Publicado: (2016)

Lateral habenula dysfunctions in Tm4sf2(−/y) mice model for neurodevelopmental disorder
por: Murru, Luca, et al.
Publicado: (2021)

TM4SF5-Mediated Regulation of Hepatocyte Transporters during Metabolic Liver Diseases
por: Kim, Ji Eon, et al.
Publicado: (2022)

TM9SF4 is an F-actin disassembly factor that promotes tumor progression and metastasis
por: Meng, Zhaoyue, et al.
Publicado: (2022)

Prognostic significance of TM4SF1 and DDR1 expression in epithelial ovarian cancer
por: Huang, Zhijiong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_elvtul7ti0ropmapn0is4in8k7